cro.directory
← Compare landing

Axcelead Drug Discovery Partners, Inc. vs Southern Research

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryAxcelead Drug Discovery Partners, Inc.Southern Research
SummaryAxcelead provides integrated drug discovery research services to pharmaceutical companies, biotech ventures, and academic institutions. Founded in 2017 from Takeda's drug discovery research base, the company offers expertise across small molecules, nucleic acids, antibodies, and multiple therapeutic modalities.Leading contract research organization offering preclinical and clinical research services across infectious disease, oncology, and rare diseases, with specialized capabilities in bioanalytical labs, BSL-3 facilities, and in vivo models.
Services
  • Discovery Research
  • Target Identification & Validation
  • High-Throughput Screening
  • Medicinal Chemistry
  • Computational & In-Silico Drug Discovery
  • Preclinical In Vitro Studies
  • In Vitro Pharmacology
  • In Vitro ADME / DMPK
  • Safety Pharmacology
  • Genetic Toxicology
  • Preclinical In Vivo Studies
  • In Vivo Efficacy Models
  • In Vivo PK / PD Studies
  • GLP Toxicology
  • Specialized & Large-Animal Models
  • Bioanalysis
  • Biomarker Assays
  • Flow Cytometry Services
  • Translational Research
  • Immunology & Inflammation Services
  • Oncology Specialty Services
  • CNS Specialty Services
  • Cardiovascular & Metabolic Specialty Services
  • Pathology & Histology Services
  • Genomics & Sequencing Services
  • Proteomics Services
  • Bioinformatics & Data Science
  • Discovery Research
  • High-Throughput Screening
  • Medicinal Chemistry
  • In Vitro ADME / DMPK
  • Safety Pharmacology
  • Preclinical In Vivo Studies
  • In Vivo Efficacy Models
  • In Vivo PK / PD Studies
  • GLP Toxicology
  • Specialized & Large-Animal Models
  • Bioanalysis
  • Clinical Trial Services
  • Pathology & Histology Services
Modalities
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Antibody-Drug Conjugate (ADC)
  • Oligonucleotide
  • mRNA
  • Peptide
Data not yet provided.
Indications
  • Oncology
  • Immunology
  • Neurology
  • Metabolic
  • Cardiovascular
  • Nephrology
  • Oncology
  • Infectious Disease
  • Rare Disease
Phases
  • Discovery
  • Preclinical (General)
  • Preclinical (IND-Enabling)
  • Discovery
  • Preclinical (General)
Sourcing models
  • Full-Service Outsourcing (FSO)
  • Full-Service Outsourcing (FSO)
LocationsData not yet provided.
  • Headquarters, Birmingham, Alabama, United States
CertificationsData not yet provided.Data not yet provided.

Find similar companies

Axcelead Drug Discovery Partners, Inc. alternatives · Southern Research alternatives

Markdown mirror: /compare/axcelead/southernresearch.md